Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The Gastrointestinal syndrome of chronic brucellosis

This is a preview of subscription content, log in to check access.

Bibliography

  1. 1.

    Angle, F. E., Algie, W. H., Baumgartner, L., and Lunsford, W. F., Skin testing for brucellosis in school children, Annals of Internal Medicine, 12:495, 1938.

  2. 2.

    Amoss, H. L., Localization of Brucella, International Clinics, 4:93, 1931.

  3. 3.

    Bang, B., The etiology of contagious abortion, Zeitschr. f. Tiermedizin, 1:241, 1897.

  4. 4.

    Benning, H. M., Chronic brucellosis: success of treatment with Brucellin Journal of the American Medical Association, 130:320, 1946.

  5. 5.

    Bruce, D., Notes on the discovery of the microorganism in Malta Fever, Practitioner, 39:161, 1887.

  6. 6.

    Craig, C. F., The symptomatology and diagnosis of Malta Fever with the report of additional cases, International Clinics, 57:730, 1905.

  7. 7.

    Evans, Alice, Chronic Brucellosis, Journal of the American Medical Association, 103:665, 1934.

  8. 8.

    Ferenbaugh, T. L., Endemic Mediterranean fever, (Malta Fever) in southwest Texas, Journal of the American Medical Association, 57:730, 1911.

  9. 9.

    Harris, H. J., Undulant fever (brucellosis). Difficulties in diagnosis and treatment, New York State Journal of Medicine, 37:1295, 1937. brucellosis with chloramphenicol and aureomycin, Journal of the American Medical Association, 142:149, 1950.

  10. 11.

    Huddleson, I. F., Brucellosis in man and animals, The Commonwealth Fund, New York, 1943.

  11. 12.

    Manchester, R. C., The clinical manifestation and diagnosis of Chronic brucellosis, Annals of Internal Medicine, 16:950, 1942.

  12. 13.

    Marston, J. A., Report on fever (Malta), Army Medical Report, 3:486, 1861.

  13. 14.

    Ralston, R. J. and Payne E. H., Treatment of chronic brucellosis with chloramphenicol and aureomycin, Journal of the American Medical Association, 142:159, 1950.

  14. 15.

    Spink, W. W., Pathogenesis of human brucellosis with respect to prevention and treatment, Annals of Internal Medicine, 29:238, 1948.

  15. 16.

    Spink, W. W., Hall, W. H., Shaffer, J. M., and Braude, A. I., Human brucellosis, its specific treatment with a combination of streptomycin and sulfadiazine, Journal of the American Medical Association, 136:382, 1948.

  16. 17.

    Spink, W. W., Braude, A. I., Castaneda, M. R., and Goytia, R. S., Aureomycin therapy in human brucellosis due to Brucella melitensis, Journal of the American Medical Association, 138:1145, 1948.

  17. 18.

    Spink, W. W., and Yow, E. M., Aureomycin, present status in the treatment of human infections, Journal of the American Medical Association, 141:964, 1949.

  18. 19.

    Traum, J., Annual report of the Chief, Bureau of Animal Industry, United States Department of Agriculture, p. 30, 1914.

  19. 20.

    FOR ADDITIONAL REFERENCES the reader is referred to the excellent monograph by Huddleson.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gauss, H. The Gastrointestinal syndrome of chronic brucellosis. Amer. Jour. Dig. Dis. 17, 323–332 (1950). https://doi.org/10.1007/BF03002581

Download citation

Keywords

  • Gall Bladder
  • Brucellosis
  • Aureomycin
  • Human Brucellosis
  • Diazine